1 / 48

CASE PRESENTATION

CASE PRESENTATION. Zshari Zxilka T. Tanggol Medical Intern Department of Obstetrics and Gynecology July 2010. General Data. 35 y/o G1P1 (1001) Female Married Roman Catholic Tuguegarao , Cagayan. Chief Complaint. Scanty menses ( Hypomenorrhea ). Past Medical History.

quana
Download Presentation

CASE PRESENTATION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CASE PRESENTATION ZshariZxilka T. Tanggol Medical Intern Department of Obstetrics and Gynecology July 2010

  2. General Data • 35 y/o G1P1 (1001) • Female • Married • Roman Catholic • Tuguegarao, Cagayan

  3. Chief Complaint • Scanty menses (Hypomenorrhea)

  4. Past Medical History • Patient denied any major medical illnesses • Operation/s: s/p Primary CS for CPD (2008, Spain) s/p endometrial curettage (2008, Spain) • No known allergies • No history of blood transfusions • No use of exogenous hormones

  5. Family History (+) Diabetes mellitus – mother (-) Hypertension, bronchial asthma, heart disease, cancer, thyroid abnormalities

  6. Personal and Social History • Patient claimed good interpersonal relationships • Nonsmoker • Non-alcoholic beverage drinker

  7. Menstrual History • Menarche: 12 y/o • Regular • 2-3 days • 2-3 pads per day, moderately soaked • (-) pain • LMP: June 28, 2010 • PMP: May 2010

  8. Obstetric History • G1P1 (1001)

  9. Gynecologic History • Coitarche: 25 • Sexual Partner: 1 • Family Planning Method: None • Last Pap smear (Nov 2009): Normal • (-) use of OCPs • (-) abnormal vaginal discharge

  10. History of Present Illness 2 years PTA • (+) Patient underwent primary caesarian section for CPD • (+) post-op fever • (-) nausea, vomiting • (-) difficulty in breathing • Patient given unrecalled IV antibiotics • USG done which showed an intrauterine mass (infection?): advised endometrial curettage

  11. History of Present Illness Within the same year (August 26, 2008) (+) Patient underwent endometrial curettage  Discharged after 6 days with an improved condition

  12. History of Present Illness 1 year PTA (5 months after giving birth) (+) resumption of menses, but was now scanty, consuming 1 minimally soaked pantyliner in 1 day lasting for 1-2 days (+) hypogastric pains, 7/10 intensity, nonradiating (+) mild fever 8 months PTA (+) persistence of symptoms (+) infertility  Sought consult with private MD in local hospital, USG done was unremarkable: referred to our institution for further evaluation and management ADMISSION

  13. Review of Systems General: no weight loss, anorexia, easy fatigability Eye: no visual dysfunction, itchiness, lacrimation or redness Ears: no dizziness, tinnitus, deafness, discharge or vertigo Nose: no congestion, no discharge, no hyperemia Mouth: no lesions or discharges Neck: no hoarseness or stiffness

  14. Review of Systems • Pulmonary: no dyspnea, no cough • Cardiac: no chest pains, no palpitations, no PND • Vascular: no phlebitis, varicosities, cyanosis • Gastrointestinal: no change in bowel movements, vomiting • Genitourinary: no dysuria, frequency, urgency, flank pains • Endocrine: no polyuria, polydipsia, polyphagia, heat/cold intolerance

  15. Review of Systems • Musculoskeletal: no joint stiffness, swelling or numbness, • Hematopoietic: no pallor or easy bruisability • Neurologic: no headache, vertigo or seizures • Psychiatric: no anxiety, depression, interpersonal relationship difficulties, illusion, delusion

  16. Physical Examination • Awake, conscious, coherent, ambulatory • Not in cardiorespiratory distress • Vital Signs: 120/80 mmHg, 74 bpm regular, 20 cpm regular, 36.9°C • Weight: 61.5 kg • Height: 150 cms • BMI: 27.33 kg/m2 (Normal)

  17. Physical Examination • Skin: warm, smooth • Head: normocephalic, normal pattern of distribution • Face: no facial asymmetry • Eyes: pink palpebral conjunctivae, anictericsclerae, pupils 2-3mm briskly reactive to light • Ears: patent ear canal; tympanic membrane non perforated, pearly white, with intact cone of light, bilateral • Nose: nasal septum midline, pink nasal mucosa, no nasal congestion. • Throat: non-hyperemictonsillopharyngeal walls

  18. Physical Examination • Neck: supple neck, no masses, no lymphadenopathies • Chest/Lungs: symmetrical chest expansion, no rib retractions, equal tactile and vocal fremitus; clear breath sounds in all lung fields • Breast/Thorax: symmetrical, no palpable masses or tenderness • Heart: adynamicprecordium, normal rate and regular rhythm, apex beat at 5th L ICS-MCL, no heaves, no thrills, no murmurs.

  19. Physical Examination • Abdomen: Flabby, normoactive bowel sounds, tympanitic, soft, nontender, no palpable masses, liver not enlarged • External pelvic examination: No lesions, redness, excoriations, hyper/hypopigmentations • IE: Cervix is short, soft, closed; uterus not enlarged, no adnexal masses or tenderness • Full and equal pulses • No bipedal edema, no cyanosis

  20. Physical Examination • Extremities: full and equal pulses, no edema, no cyanosis, no clubbing • Neurologic: essentially normal • Extremities: grossly normal extremities, no cyanosis, deformity, swelling, redness, tenderness, limitation of motion. • Pulses: full and equal

  21. Subjective SALIENT FEATURES • 35 y/o female • s/p primary CS for CPD (2008, Spain) • s/p endometrial curettage (2008, Spain) • (+) scanty menses preceded by hypogastric pains and mild fever • (+) infertility • Nonhypertensive, nondiabetic, non-asthmatic • No use of exogenous hormones • MHx: 12 yo/reg/2-3d/2-3ppd/(-) • G1P1 (1001)

  22. Objective SALIENT FEATURES • Conscious, coherent, not in CP distress • Stable vital signs • Abdomen: Flabby, soft and nontender • External pelvic examination: No lesions, redness, excoriations, hyper/hypopigmentations • IE: Cervix is short, soft, closed; uterus not enlarged, no adnexal masses or tenderness • Full and equal pulses; No bipedal edema, no cyanosis

  23. Clinical Impression • Asherman’s Syndrome

  24. Differentials • Amenorrhea without secondary sexual characteristics – rule out • Amenorrhea/Hypmenorrhea with secondary sexual characteristics

  25. Differentials Female genital tract • Anatomic abnormalities: such as imperforate hymen, transverse vaginal septum and hypoplasia or absence of uterus, cervix and vagina • Iatrogenic causes leading to anatomic abnormalities: Asherman’s syndrome • Excessive blood levels of endogenous or exogenous estrogen or progesterone will cause amenorrhea • Congenitally absent endometrium (rare)

  26. Differentials • Pituitary • Malformations • Inflammation: sarcoidosis, tuberculosis • Neoplasm which can cause hypopituitarism: adenomas • Trauma (from postpartum hemorrhage): Sheehan syndrome Ovary • Malformations • Intoxication • Neoplasm • Trauma • systemic diseases Hyperthyroidism Adrenal hyperplasia or Addison’s

  27. ASHERMAN’S SYNDROME

  28. Asherman’s Syndrome (AS) • J.G. Asherman described the syndrome that now bears his name in a 1948 publication in what was then known as the Journal of Obstetrics and Gynecology of the British Empire • Also known as intrauterine adhesions (IUA) or uterine synechiae • Characterized by the presence of adhesions and/or fibrosis within the uterine cavity due to scars

  29. Asherman’s Syndrome: Causes • Intraoperative or post-operative complications of uterine evacuations for menorrhagia, pregnancy termination or postpartum hemorrhage • Occurs most frequently after a Dilatation &Curettage (D&C) is performed on a recently pregnant uterus, following a missed or incomplete abortion, birth or elective termination to remove retained products of conception

  30. Asherman’s Syndrome: Causes • Pelvic surgeries including caesarian section and myomectomy • Pelvic irradiation and IUDs • Severe pelvic inflammatory disease • Infection with tuberculosis or schistosomiasis

  31. Asherman’s Syndrome: Incidence and Prevalence • Risk of developing Asherman’s from a D&C is 25% 2-4 weeks after delivery and 30.9% of D&Cs for missed miscarriages and 6.4% of D&Cs for incomplete miscarriages • Risk of AS also increases with the number of procedures •  A 5% estimate of D&Cs result in AS, although true prevalence is unclear • About 13% of 78 infertile women scheduled for IVF treatment were found to have intrauterine adhesions after evaluation with diagnostic hysteroscopy

  32. Uterus

  33. Asherman’s Syndrome: Pathophysiology Presence of intrauterine scars resulting to adhesions Trauma to the endometrial lining (e.g. D&C performed for abortion or delivery) Menstrual irregularities, infertility or recurrent abortions Obliteration of uterine cavity leading to failure to respond to estrogen

  34. Asherman’s Syndrome: Illustration

  35. Asherman’s Syndrome: Features • Menstrual irregularities (hypomenorrhea, amenorrhea) following uterine evacuation procedures • Hypogastric pains preceding menstruation • Infertility or recurrent spontaneous abortion, with or without amenorrhea

  36. Asherman’s Syndrome: Features • Amenorrhea, menstrual irregularities, recurrent pregnancy loss and spontaneous abortion are already associated with severe AS

  37. Asherman’s Syndrome: Risks and Complications • Endometriosis • Placentation abnormalities • Miscarriage • Cervical incompetence • IUGR • Premature birth • Uterine rupture

  38. Asherman’s Syndrome: Classification Classification systems take into account the following factors: • amount of functioning residual endometrium • menstrual pattern • obstetric history • other factors which are thought to play a role in determining the prognoses • location and severity of adhesions inside the uterus

  39. Asherman’s Syndrome: Classification* Stage I – mild Stage II – moderate Stage III and IV – severe *American Fertility Society/American Society for Reproductive Medicine classification of intrauterine adhesions

  40. DIAGNOSIS History and Physical Examination Procedures • Hysteroscopy – for direct visualization of the uterus • Sonohysterography • Hysterosalpingogram (HSG)

  41. MANAGEMENT • Hysteroscopic resection/operative hysteroscopy – method of choice for management of intrauterine synechiae • Estrogen therapy – conjugated estrogen 2.5-5mg per day for 1-2 months • Estrogen therapy in combination with intrauterine device (balloons, stents, catheter)

  42. MANAGEMENT • Hysteroscopy can also be combined with laparoscopy

  43. MANAGEMENT: Hysteroscopy • Thin and fragile synechiae may be divided with the tip of a rigid diagnostic hysteroscope • Thicker lesions may then require division by semirigid or rigid scissors or energy based instruments such as resectoscope or an operative hysteroscope with Nd:YAG laser

  44. PREVENTION • Minimal pregnancy D&C-related procedures • Use of Misoprostol for evacuation following miscarriage or birth for retained placenta and hemorrhage • Ultrasound-guided D&C • Prophylactic antibiotics in patients who opt to defer uterine evacuation following fetal loss

  45. PROGNOSIS • Reproductive outcome depends on the extent of the preoperative endometrial damage • For mild to moderate adhesions, you might expect a 60-80% chance of successful pregnancy after repair •  In moderate to severe Asherman’s syndrome, recurrence rates range between 20-40% and 40-50%

  46. THANK YOU! 

More Related